MONTREAL, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Today, AbbVie (NYSE: ABBV), jointly with the adMare BioInnovations, announced the launch of the AbbVie Biotech Innovators Award, a prize to help foster innovation and support growth in Quebec's life sciences sector.

LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 5, 2026.

Meta reportedly in talks to buy AI chips from Google, Best Buy earnings beat Wall Street expectations Morning Brief: Market Sunrise anchor Ramzan Karmali breaks down the latest market news for November 25, 2025. According to a report in The Information, Meta is reportedly in talks to spend billions on purchasing Google AI chips.

Expanded Iron Dome funding drives long-term demand for Rimon's core technology Expanded Iron Dome funding drives long-term demand for Rimon's core technology

ATHENS, Greece, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Performance Shipping Inc. (NASDAQ: PSHG) (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, today reported net income of $3.9 million for the third quarter of 2025. This result is compared to a net income of $12.4 million for the same period in 2024. Earnings per share, basic and diluted, for the third quarter of 2025 were $0.28 and $0.10, respectively.

Best Buy Co Inc (NYSE:BBY) raised its full-year forecast on Tuesday after stronger demand for new consumer electronics helped the retailer post quarterly revenue and profit ahead of Wall Street expectations. The company reported non-GAAP earnings of $1.40 per share, beating estimates by $0.09, while revenue rose 2.3% from a year earlier to $9.67 billion, surpassing analysts' forecasts by about $80 million.

BSX posts stronger Q3 margins as growth in EP and WATCHMAN lifts product mix despite tariff pressure.

NRG's surging earnings estimates, high ROE and strong price gains sharpen its edge in a shifting clean-energy utilities market compared with NEE.

Dick's Sporting Goods (DKS) came out with quarterly earnings of $2.78 per share, beating the Zacks Consensus Estimate of $2.62 per share. This compares to earnings of $2.75 per share a year ago.

NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced initial results on the combination of the Allurion Program with low-dose tirzepatide therapy to optimize muscle mass and GLP-1 adherence. 76 patients treated with the Allurion Smart Capsule were started on low-dose tirzepatide after completing their first 45 days of balloon therapy. The starting dose of tirzepatide was 2.5mg and.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that its Phase 2 clinical trial evaluating intranasal foralumab in patients with amyotrophic lateral sclerosis (ALS) has been accepted into the ALS MyMatch Program at the Sean M Healey & AMG Center for ALS at Mass General Brigham. The study, supported by a grant from the ALS Association, will be led by Principal Investigators Suma Babu and James Berry at Mass General Brigham.

V is rated a Buy, supported by its asset-light model, exceptional profitability, and strong cash flow generation. V's resilient consumer spending, innovation in stablecoins, and robust shareholder returns reinforce its long-term investment appeal. Despite high valuation multiples, V trades at a 17% discount to its 5-year average P/E, offering a compelling risk-reward profile.

Artificial intelligence server maker Hewlett Packard Enterprise said on Tuesday it has won a $931 million contract from a support agency of the U.S. Department of War for providing cloud services for its data centers.

Dell Technologies Inc. (NYSE: DELL) will release earnings results for the third quarter after the closing bell on Tuesday, Nov. 25.

CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.

New York, New York--(Newsfile Corp. - November 25, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today announced that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO) approved 'daznelimgene lisbac' for the non-proprietary name for the Company's HER2 targeted Listeria monocytogenes-based cancer immunotherapy product candidate OST-HER2. OST-HER2 is currently being developed for the prevention or delay of recurrent, fully resected, pulmonary metastatic osteosarcoma.

LONDON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) ("RedCloud" or the "Company") the technology company behind the RedAI trading platform for businesses across Fast Moving Consumer Goods (“FMCG”) industry, today announced that CEO Justin Floyd will close out the year by participating at two prestigious global conferences in Japan and Qatar.

Zoom Video Communications Inc (NASDAQ:ZM) raised its full-year revenue and profit forecasts on Tuesday after topping Wall Street estimates for the October quarter, buoyed by strong adoption of its artificial intelligence tools and steady enterprise demand. The company reported third-quarter revenue of $1.23 billion, above its $1.21 billion to $1.22 billion outlook, while adjusted earnings per share came in at $1.52, beating guidance of $1.42 to $1.44.

PLANO, Texas--(BUSINESS WIRE)---- $TYL #TylerTech--Tyler Technologies announced that the city of Homestead, Florida, has launched Tyler's Enterprise Permitting & Licensing cloud platform.

Analog Devices (ADI) came out with quarterly earnings of $2.26 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $1.67 per share a year ago.